AzTrials
AzTrials

ICU Patients Dependant on Mechanical Ventilation : Safest Mode of Performing Percutaneous Tracheostomy Among ICU Ventilated Unweanable PatientsNCT02754921

Percutaneous Dilatational Tracheostomy: Ultra-perc Versus Ciaglia Blue Dolphin

A study testing percutaneous dilatational tracheostomy using Ultra-Perc and Percutaneous dilatational tracheostomy using Ciaglia Blue Dolphin in people with ICU Patients Dependant on Mechanical Ventilation : Safest Mode of Performing Percutaneous Tracheostomy Among ICU Ventilated Unweanable Patients, run by Mohamed Sayed Mohamed Abbas.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to compare Ultra-perc single stage dilator technique with Ciaglia Blue Dolphin ballon dilatation technique for intubated unweanable ICU patients with respect to procedure difficulties and complications. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
percutaneous dilatational tracheostomy using Ultra-Perc and Percutaneous dilatational tracheostomy using Ciaglia Blue Dolphin
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
Jan 2013to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • sepsis
  • cerebrovascular accidents
  • cervical cord injury
  • traumatic brain injury
  • post arrest and chronic obstructive pulmonary disease

Who cannot join

  • patient or family refusal
  • emergency tracheostomy
  • distorted abnormal anatomy
  • bleeding diathesis
  • morbid obesity
  • previous tracheostomy
  • infected surgical site
  • Adult respiratory distress syndrome patients requiring high positive end expiratory pressure and high oxygen demands

About this study

Official title: Percutaneous Dilatational Tracheostomy: Ultra-perc Single Stage Dilator Technique Versus Ciaglia Blue Dolphin Ballon Dilatation Technique for Intubated Unweanable ICU Patients

The aim of this study is to compare Ultra-perc single stage dilator technique with Ciaglia Blue Dolphin ballon dilatation technique for intubated unweanable ICU patients with respect to procedure difficulties and complications.

Read the detailed description

The investigators conducted a prospective randomized trial to compare Ultra-perc single stage dilator technique (UP) and Ciaglia Blue Dolphin ballon dilatation technique (CBD) From January 2013 to December 2015.

The investigators compared the two groups as regards Procedure difficulties including difficult dilatation, difficult tube insertion, failed tube insertion, false passage and tracheal stoma over dilatation. and Procedure complications including cardiac arrest, pneumothorax, pneumomediastinum, subcutaneous emphysema, hemorrhage and lung atelectasis.

Being tested
percutaneous dilatational tracheostomy using Ultra-Perc, Percutaneous dilatational tracheostomy using Ciaglia Blue Dolphin

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • percutaneous dilatational tracheostomy using Ultra-PercProcedure or surgery

    Procedure difficulties and complications faced while doing percutaneous dilatational tracheostomy using Ultra-Perc

  • Percutaneous dilatational tracheostomy using Ciaglia Blue DolphinProcedure or surgery

    Procedure difficulties and complications faced while doing percutaneous dilatational tracheostomy using Ciaglia Blue Dolphin

Study groups in NCT02754921
Study groupRoleWhat they receive
Ultra-percExperimentalNot described
Receives: Procedure: percutaneous dilatational tracheostomy using Ultra-Perc
Ciaglia Blue DolphinExperimentalNot described
Receives: Procedure: Percutaneous dilatational tracheostomy using Ciaglia Blue Dolphin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Procedure difficulties including difficult dilatation, difficult tube insertion, failed tube insertion, false passage and tracheal stoma over dilatation.

    Measured: within 2 years

  2. Procedure complications including cardiac arrest, pneumothorax, pneumomediastinum, subcutaneous emphysema, hemorrhage and lung atelectasis.

    Measured: within 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2016 (estimated)
  2. Study startJan 2013
  3. Primary completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02754921
Sponsor's protocol ID
MSAT-2
Status last verified
Apr 2016
First submitted
25 Apr 2016
Last updated
28 Apr 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes

Publications

  • Cianchi G, Zagli G, Bonizzoli M, Batacchi S, Cammelli R, Biondi S, Spina R, Peris A. Comparison between single-step and balloon dilatational tracheostomy in intensive care unit: a single-centre, randomized controlled study. Br J Anaesth. 2010 Jun;104(6):728-32. doi: 10.1093/bja/aeq087. Epub 2010 Apr 21.

    PubMed 20413380

Questions about this trial

What is this clinical trial studying?

A study testing percutaneous dilatational tracheostomy using Ultra-Perc and Percutaneous dilatational tracheostomy using Ciaglia Blue Dolphin in people with ICU Patients Dependant on Mechanical Ventilation : Safest Mode of Performing Percutaneous Tracheostomy Among ICU Ventilated Unweanable Patients, run by Mohamed Sayed Mohamed Abbas.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Procedure difficulties including difficult dilatation, difficult tube insertion, failed tube insertion, false passage and tracheal stoma over dilatation. (time frame: within 2 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02754921, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in